$419M
$5.58 Million
0.0% of portfolio
1,226,164
Q2 2025
Added 16.33%
-
$0
0.0% of portfolio
-
Q2 2025
Added 137.56%
$5.92B
$36.9 Million
0.0% of portfolio
1,517,097
Q2 2025
Added 4.71%
$250M
$3.37 Million
0.0% of portfolio
702,773
Q2 2025
Added 4.86%
$209M
$542,000
0.0% of portfolio
86,971
Q2 2025
Reduced 67.81%
$95.7B
$5.31 Million
0.0% of portfolio
242,880
Q2 2025
Reduced 43.89%
$2.21B
$64.6 Million
0.0% of portfolio
1,498,094
Q2 2025
Reduced 3.2%
$996M
$22.4 Million
0.0% of portfolio
353,342
Q2 2025
Reduced 10.28%
-
$0
0.0% of portfolio
-
Q2 2025
Added 95.63%
Inhibikase Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Added 849.79%
-
$0
0.0% of portfolio
-
Q2 2025
Added 18.54%
$1.23B
$10.2 Million
0.0% of portfolio
708,608
Q2 2025
Reduced 61.33%
$36.1M
$636,000
0.0% of portfolio
275,392
Q2 2025
Added 16.63%
$1.71B
$32.9 Million
0.0% of portfolio
642,001
Q2 2025
Added 9.82%
$2.05B
$81.6 Million
0.0% of portfolio
970,225
Q2 2025
Reduced 4.07%
$617M
$1.26 Million
0.0% of portfolio
342,323
Q2 2025
Reduced 0.28%
-
$0
0.0% of portfolio
-
Q1 2025
Added 135.91%
$1.59B
$90.7 Million
0.0% of portfolio
1,642,647
Q2 2025
Added 0.24%
$193M
$667,000
0.0% of portfolio
48,093
Q2 2025
Added 11.09%
Innovex International Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 10.22%
$1.35B
$49.4 Million
0.0% of portfolio
2,457,462
Q2 2025
Added 3.96%
$251M
$1.5 Million
0.0% of portfolio
912,643
Q2 2025
Added 2.47%
$18.2M
$43,000
0.0% of portfolio
19,275
Q1 2022
Added 0.92%
-
$0
0.0% of portfolio
-
Q2 2025
Added 190.15%
$195M
$3.61 Million
0.0% of portfolio
513,249
Q2 2025
Reduced 0.96%
$36.1M
$225,000
0.0% of portfolio
124,129
Q2 2025
Added 38.96%
Inovio Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 75.96%
$161M
$1.33 Million
0.0% of portfolio
331,772
Q2 2025
Reduced 66.73%
-
$0
0.0% of portfolio
-
Q2 2025
Added 169.41%
Insight Molecular Dia Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 20.04%
$2.01B
$78.6 Million
0.0% of portfolio
1,307,782
Q2 2025
Reduced 2.22%
$246M
$3.69 Million
0.0% of portfolio
452,145
Q2 2025
Added 6.76%
$752M
$27.7 Million
0.0% of portfolio
743,642
Q2 2025
Reduced 3.13%
-
$0
0.0% of portfolio
-
Q1 2025
Added 18.93%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 54.38%
$2.84B
$67.1 Million
0.0% of portfolio
1,299,957
Q2 2025
Added 6.28%
$1.26B
$34.7 Million
0.0% of portfolio
2,826,465
Q2 2025
Added 2.88%
Integra Lifesciences Hldgs C
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 12.63%
$1.31B
$13.4 Million
0.0% of portfolio
1,609,128
Q2 2025
Added 2.97%
$868M
$37.9 Million
0.0% of portfolio
4,039,285
Q2 2025
Reduced 10.44%
$107M
$351,000
0.0% of portfolio
65,305
Q2 2025
Added 4.65%
$17.3M
$31,000
0.0% of portfolio
17,488
Q3 2024
Reduced 61.13%
Intensity Therapeutics Inc
-
$0
0.0% of portfolio
-
Q4 2023
New
$2.55B
$14 Million
0.0% of portfolio
1,880,583
Q2 2025
Reduced 18.81%
$21.4B
$326,000
0.0% of portfolio
2,833
Q4 2024
Reduced 8.99%
$4.84B
$7.35 Million
0.0% of portfolio
192,688
Q2 2025
Added 4.66%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 6.39%
$1.68B
$45.7 Million
0.0% of portfolio
2,183,074
Q2 2025
Reduced 0.39%
$2.89B
$32 Million
0.0% of portfolio
2,021,759
Q2 2025
Reduced 1.72%
$549M
$6.74 Million
0.0% of portfolio
668,137
Q2 2025
Reduced 6.33%